This inventor holds 4 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 1 EPO patent. Top assignee: Shanghaitech University. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Innovations in Anti-Tumor Applications by Xiaoling Song
Introduction
Xiaoling Song is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of pharmacology, particularly in the development of compounds for anti-tumor applications. With a total of three patents to her name, her work focuses on innovative solutions for cancer treatment.
Latest Patents
Xiaoling Song's latest patents include groundbreaking research on ALK protein regulators and their anti-tumor applications. One of her notable inventions is a compound of general formula (I), which, along with a compound of general formula (III), demonstrates a wide range of pharmacological activities. These compounds are designed to degrade specific proteins and inhibit their activity, making them valuable in the treatment of tumors and cancers. The compounds consist of three main components: a small molecule compound (SMBP) that binds to a protein, a linker (LIN), and a ubiquitin ligand (ULM). This innovative design allows for targeted protein degradation, enhancing the efficacy of cancer treatments.
Career Highlights
Xiaoling Song is affiliated with Shanghaitech University, where she continues her research and development in the field of pharmacology. Her work has garnered attention for its potential to revolutionize cancer therapies through the use of novel compounds that target specific proteins involved in tumor growth.
Collaborations
Throughout her career, Xiaoling has
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile